Nicola Currey
Sydney, NSW 2010, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
MCC Gene Silencing Is a CpG Island Methylator Phenotype-Associated Factor That Predisposes Colon Cancer Cells to Irinotecan and Olaparib.
Journal: Cancers
Published: May 27, 2022
Tetranucleotide and Low Microsatellite Instability Are Inversely Associated with the CpG Island Methylator Phenotype in Colorectal Cancer.
Journal: Cancers
Published: June 10, 2021
Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and Cancer.
Journal: Cellular and molecular gastroenterology and hepatology
Published: April 10, 2018
Microsatellite Instability in Mouse Models of Colorectal Cancer.
Journal: Canadian journal of gastroenterology & hepatology
Published: November 02, 2017
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.
Journal: Science translational medicine
Published: September 06, 2016
Proteogenomic Analysis Identifies a Novel Human SHANK3 Isoform.
Journal: International journal of molecular sciences
Published: January 15, 2015
HIF1α deficiency reduces inflammation in a mouse model of proximal colon cancer.
Journal: Disease models & mechanisms
Published: November 04, 2014
MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.
Journal: International journal of cancer
Published: November 07, 2013
Sulindac activates NF-κB signaling in colon cancer cells.
Journal: Cell communication and signaling : CCS
Published: August 06, 2013
KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.
Journal: International journal of cancer
Published: July 29, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026